Cellulite News and Research

RSS
Cellulite describes a condition that is claimed to occur in most women, where the skin of the lower limbs, abdomen, and pelvic region becomes dimpled.
Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

Auxilium Pharmaceuticals reports positive results from phase IIa Frozen Shoulder Syndrome clinical trial

Auxilium Pharmaceuticals reports positive results from phase IIa Frozen Shoulder Syndrome clinical trial

Syneron dismisses U.S. patent infringement suit against Eclipse Aesthetics, EndyMed

Syneron dismisses U.S. patent infringement suit against Eclipse Aesthetics, EndyMed

The Journal of Urology publishes results from BioSpecifics XIAFLEX trials on Peyronie's disease

The Journal of Urology publishes results from BioSpecifics XIAFLEX trials on Peyronie's disease

Cynosure closes underwritten registered public offering of class A common stock

Cynosure closes underwritten registered public offering of class A common stock

Gateway Aesthetic announces addition of three new procedures

Gateway Aesthetic announces addition of three new procedures

Additional data from Auxilium XIAFLEX phase III studies on Peyronie's disease

Additional data from Auxilium XIAFLEX phase III studies on Peyronie's disease

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Health Canada approves XIAFLEX for Dupuytren's contracture

Health Canada approves XIAFLEX for Dupuytren's contracture

FDA clears Syneron Medical's elos Plus system

FDA clears Syneron Medical's elos Plus system

BioSpecifics commences XIAFLEX Phase II trial in human lipoma

BioSpecifics commences XIAFLEX Phase II trial in human lipoma

Positive results from BioSpecifics’ XIAFLEX Phase III clinical program on Peyronie's disease

Positive results from BioSpecifics’ XIAFLEX Phase III clinical program on Peyronie's disease

Positive results from Auxilium’s XIAFLEX phase III studies on Peyronie's disease

Positive results from Auxilium’s XIAFLEX phase III studies on Peyronie's disease

Viora offers Reaction Rent-to-Own program to medical aesthetic practitioners in Canada

Viora offers Reaction Rent-to-Own program to medical aesthetic practitioners in Canada

BistroMD, 'The Doctors' team up to help young woman look lose weight

BistroMD, 'The Doctors' team up to help young woman look lose weight

Actelion, Auxilium partner to develop and commercialize XIAFLEX

Actelion, Auxilium partner to develop and commercialize XIAFLEX

Birmingham dermatologist first to offer anti-cellulite Cellulaze procedure

Birmingham dermatologist first to offer anti-cellulite Cellulaze procedure

AACS 2012 announces record attendance at annual scientific meeting

AACS 2012 announces record attendance at annual scientific meeting